09 January 2002
Markers of inflammation and coronary artery disease.
Gordon A Ferns, Salam M SaadeddinMed Sci Monit 2002; 8(1): RA5-12 :: ID: 420955
Abstract
Many recent experimental and clinical studies have provided evidence forthe presence of inflammation in atherosclerotic lesions. Ongoing inflammatory reactions within coronaryatherosclerotic plaques are increasingly thought to be crucial determinants of the clinical course ofpatients with coronary artery disease (CAD). These facts lead to a search for reliable markers reflectingthe inflammatory process in the atherosclerotic plaques. Circulating markers may consist of cytokinesdirectly released from inflammatory cells present in the plaques and tissues exposed to recurrent ischemiaas well as other reactants produced in response to these cytokines such as adhesion molecules and acutephase proteins. Recent studies suggest that markers of inflammation may reflect different aspects ofthe atherothrombotic process at different points in the continuum of acute coronary syndromes, have apotential role for the prediction of risk for developing CAD, and may correlate with severity and futurerisk for CAD. In spite of these findings, the clinical utility of measuring these markers is limitedby the availability of reproducible diagnostic test assays. In addition, it remains to be determinedwhether markers of inflammation actually have a causal relation with cardiovascular disease, or simplyreflect the underlying disease process. Such determination becomes important with the potential use ofthese markers in targeting preventive therapies. Therefore, further well-designed prospective evaluationof each of these markers is needed before their use in routine practice.
Keywords: Acute-Phase Proteins, Apolipoproteins, Biological Markers, C-Reactive Protein, Cell Adhesion Molecules, Coronary Arteriosclerosis, Cytokines, Fibrinogen, Interleukin-1, Interleukin-6, Serum Amyloid A Protein
953 230
Editorial
01 November 2023 : Editorial
Editorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is DeclaredDOI: 10.12659/MSM.942960
Med Sci Monit 2023; 29:e942960
In Press
28 Nov 2023 : Clinical Research
Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and ...Med Sci Monit In Press; DOI: 10.12659/MSM.942122
28 Nov 2023 : Clinical Research
Long-Term Outcomes of Decompression and Grafting in Acute Pathological Proximal Femur Fractures in Children...Med Sci Monit In Press; DOI: 10.12659/MSM.943031
27 Nov 2023 : Clinical Research
Comparison of Outcomes from Emergency Admissions to a Major Trauma Center in Turkey of 1646 Elderly Patient...Med Sci Monit In Press; DOI: 10.12659/MSM.942916
27 Nov 2023 : Clinical Research
Evaluating Modified Ultrasound-Guided Serratus Anterior Plane Block for Enhanced Postoperative Recovery in ...Med Sci Monit In Press; DOI: 10.12659/MSM.942757
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292